Glimicut MP 1mg/500mg/15mg Tablet SR
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimicut MP 1mg/500mg/15mg Tablet SR
Metformin/glimepiride/pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication managing blood glucose. This therapy, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It facilitates efficient insulin use, subsequently reducing blood sugar. Dosage and duration for Metformin/glimepiride/pioglitazone should strictly follow your physician's instructions. Administer with food to minimize gastric discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the regular regimen. Never double the dose. Overdosage can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before initiating treatment. Consult your physician prior to use during pregnancy or breastfeeding. Kidney function will be assessed before commencing therapy. Limit alcohol consumption, as it may amplify side effects.
Primary Ingredients of Glimicut MP 1mg/500mg/15mg Tablet SR
There is no text provided to rephrase.
Uses of Glimicut MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimicut MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimicut MP 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glimicut MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimicut MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimicut MP 1mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Glimicut MP 1mg/500mg/15mg Tablet SR works:
Glimicut MP 1mg/500mg/15mg Extended-Release tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to enhance blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimicut MP 1mg/500mg/15mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glimicut MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimicut MP 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Caution is advised when prescribing Glimicut MP 1mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severely compromised kidney function should not use Glimicut MP 1mg/500mg/15mg SR tablets. Physician consultation is recommended. Regular assessment of kidney function is prudent during treatment with this medication.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Glimicut MP 1mg/500mg/15mg SR tablets, as dose modification may be necessary. Individuals with severe liver disease should avoid this medication. Medical advice is recommended.
What if you forget to take Glimicut MP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glimicut MP 1mg/500mg/15mg SR Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimicut MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently